Dextenza Insert and Insulin Aspart Injection
Determining the interaction of Dextenza Insert and Insulin Aspart Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza Insert-Insulin Aspart Protamine and Insulin Aspart
- Dextenza Insert-Insulin aspart protamine and insulin aspart Subcutaneous
- Dextenza Insert-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Dextenza Insert-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Dextenza Insert-Insulin Aspart Protamine Injection
- Dextenza Insert-Insulin aspart, recombinant Subcutaneous
- Insulin Aspart Injection-Dextenza intraocular
- Insulin Aspart Injection-Dextran 40
- Insulin Aspart Injection-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin Aspart Injection-Dextran 75
- Insulin Aspart Injection-Dextran high molecular weight
- Insulin Aspart Injection-Dextranomer and Hyaluronate Derivatives (Deflux)